News

FUJISAWA (SEPTEMBER 30, 2024) – Elixirgen Scientific Japan, Inc (EsJ), a Japanese provider of synthetic mRNA contract development and manufacturing services, was awarded Best CDMO Finalist at Citeline Award Japan – 2024 by Citeline. Recognized for its excellence in delivering innovative and high-quality solutions in mRNA manufacturing, EsJ has demonstrated significant advancements in this field […]

Ricoh Develops a New Pathological Model for Rett Syndrome in iPSC-derived Neurons Baltimore, MD, USA (August 30, 2024) －Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery through hiPSC technology, announced today the launch of its new in vitro assay service for Rett syndrome that mimics the disease pathology. This cutting-edge assay was [...]

Baltimore-based biotechnology leader, Elixirgen Scientific, Inc. signs an agreement with Mitsubishi Tanabe Pharma America, Inc. to supply human iPSC-derived neurons and glial cells, strengthening commitment to innovation and collaboration in drug discovery. Baltimore, MD, & Jersey City, NJ, USA (July 24, 2024) – Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery and [...]

Maryland-based biotechnology leader, Elixirgen Scientific, Inc., launches Alzheimer’s Disease Panel, strengthening their commitment to quality and innovation in disease research and drug discovery. Baltimore, MD, USA (July 12, 2024) – Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery and revolutionizing cell therapy through hiPSC technology, announced today the launch of its new [...]

Baltimore, Maryland, USA (March 12, 2024) – Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery and revolutionizing cell therapy through iPSC technology, announced today that it has been accredited for ISO 9001:2015 certification. The certification is an internationally recognized standard developed by the International Organization for Standardization (ISO) that ensures a company’s [...]

Fujisawa, Japan (December 07, 2023) – Elixirgen Scientific Japan, Inc (EsJ), a Japanese provider of synthetic mRNA contract development and manufacturing services, was awarded TOP 10 CDMOs in APAC - 2023 by Pharma Tech Outlook. Recognized for its excellence in delivering innovative and high-quality solutions in mRNA manufacturing, EsJ has demonstrated significant advancements in this [...]

A joint research of Ricoh and the University of Tokyo TOKYO, March 27, 2023 – Ricoh's research group at the Biomedical R&D Department, led by Waka Lin, and Yuko Sekino, Project Professor at the Graduate School of Agriculture and Life Sciences, the University of Tokyo, have jointly demonstrated that transcription factor-induced human iPSC-derived neurons reach functional [...]